PharmaTher Introduces PatchPrint(TM) With Provisional Patent Filing and Commercialization Strategy for Microneedle Patches

AI Briefing

• – PharmaTher introduces PatchPrint, a new microneedle patch solution, with a provisional patent filing and commercialization strategy.
• – PatchPrint supports existing microneedle patch programs and expands into personalized patch solutions, including peptide patches and branded wellness patches.
• – PharmaTher aims to leverage its existing PharmaPatch experience to drive growth and commercialization of PatchPrint.